523 related articles for article (PubMed ID: 33504472)
1. Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study.
Hsu G; Kovács B
BMJ; 2021 Jan; 372():m4957. PubMed ID: 33504472
[TBL] [Abstract][Full Text] [Related]
2. Changes in Opioid and Benzodiazepine Poisoning Deaths After Cannabis Legalization in the US: A County-level Analysis, 2002-2020.
Castillo-Carniglia A; Rivera-Aguirre A; Santaella-Tenorio J; Fink DS; Crystal S; Ponicki W; Gruenewald P; Martins SS; Keyes KM; Cerdá M
Epidemiology; 2023 Jul; 34(4):467-475. PubMed ID: 36943813
[TBL] [Abstract][Full Text] [Related]
3. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
[TBL] [Abstract][Full Text] [Related]
4. Exploring the effect of Colorado's recreational marijuana policy on opioid overdose rates.
Alcocer JJ
Public Health; 2020 Aug; 185():8-14. PubMed ID: 32505041
[TBL] [Abstract][Full Text] [Related]
5. Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality.
Phillips E; Gazmararian J
J Opioid Manag; 2017; 13(4):229-239. PubMed ID: 28953315
[TBL] [Abstract][Full Text] [Related]
6. Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.
Rudd RA; Aleshire N; Zibbell JE; Gladden RM
MMWR Morb Mortal Wkly Rep; 2016 Jan; 64(50-51):1378-82. PubMed ID: 26720857
[TBL] [Abstract][Full Text] [Related]
7. Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality.
Nguyen HV; McGinty EE; Mital S; Alexander GC
JAMA Health Forum; 2024 Jan; 5(1):e234897. PubMed ID: 38241056
[TBL] [Abstract][Full Text] [Related]
8. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.
Bachhuber MA; Saloner B; Cunningham CO; Barry CL
JAMA Intern Med; 2014 Oct; 174(10):1668-73. PubMed ID: 25154332
[TBL] [Abstract][Full Text] [Related]
9. Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
Pardo B
Addiction; 2017 Oct; 112(10):1773-1783. PubMed ID: 28009931
[TBL] [Abstract][Full Text] [Related]
10. Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population.
Bradford AC; Bradford WD; Abraham A; Bagwell Adams G
JAMA Intern Med; 2018 May; 178(5):667-672. PubMed ID: 29610897
[TBL] [Abstract][Full Text] [Related]
11. Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.
Wilson N; Kariisa M; Seth P; Smith H; Davis NL
MMWR Morb Mortal Wkly Rep; 2020 Mar; 69(11):290-297. PubMed ID: 32191688
[TBL] [Abstract][Full Text] [Related]
12. Association Between Automotive Assembly Plant Closures and Opioid Overdose Mortality in the United States: A Difference-in-Differences Analysis.
Venkataramani AS; Bair EF; O'Brien RL; Tsai AC
JAMA Intern Med; 2020 Feb; 180(2):254-262. PubMed ID: 31886844
[TBL] [Abstract][Full Text] [Related]
13. Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.
Scholl L; Seth P; Kariisa M; Wilson N; Baldwin G
MMWR Morb Mortal Wkly Rep; 2018 Jan; 67(5152):1419-1427. PubMed ID: 30605448
[TBL] [Abstract][Full Text] [Related]
14. Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance.
Shover CL; Falasinnu TO; Dwyer CL; Santos NB; Cunningham NJ; Freedman RB; Vest NA; Humphreys K
Drug Alcohol Depend; 2020 Nov; 216():108314. PubMed ID: 33038637
[TBL] [Abstract][Full Text] [Related]
15. Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication.
Shover CL; Vest NA; Chen D; Stueber A; Falasinnu TO; Hah JM; Kim J; Mackey I; Weber KA; Ziadni M; Humphreys K
JAMA Netw Open; 2020 Jul; 3(7):e2010001. PubMed ID: 32662844
[TBL] [Abstract][Full Text] [Related]
16. State Medical Cannabis Laws Associated With Reduction in Opioid Prescriptions by Orthopaedic Surgeons in Medicare Part D Cohort.
Lopez CD; Boddapati V; Jobin CM; Hickernell TR
J Am Acad Orthop Surg; 2021 Feb; 29(4):e188-e197. PubMed ID: 32404683
[TBL] [Abstract][Full Text] [Related]
17. Opioid Misuse and the Availability of Medical Marijuana Through Dispensaries.
Freisthler B; Sumetsky N; Kranich C; Chadwick C; Mair C
J Stud Alcohol Drugs; 2020 Jul; 81(4):489-496. PubMed ID: 32800086
[TBL] [Abstract][Full Text] [Related]
18. Changing Trends in Opioid Overdose Deaths and Prescription Opioid Receipt Among Veterans.
Lin LA; Peltzman T; McCarthy JF; Oliva EM; Trafton JA; Bohnert ASB
Am J Prev Med; 2019 Jul; 57(1):106-110. PubMed ID: 31128955
[TBL] [Abstract][Full Text] [Related]
19. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US.
Ballreich J; Mansour O; Hu E; Chingcuanco F; Pollack HA; Dowdy DW; Alexander GC
JAMA Netw Open; 2020 Nov; 3(11):e2023677. PubMed ID: 33146732
[TBL] [Abstract][Full Text] [Related]
20. Associations of recreational cannabis dispensaries' availability, storefront signage and health benefit signs with cannabis use: findings from a representative adult sample in California, United States.
Han B; Shi Y
Addiction; 2023 Jul; 118(7):1270-1279. PubMed ID: 36680550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
